Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SYMPK - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBM10 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ZRSR2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SRRM2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
WASH1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SAFB - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC25A29 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EIF2B5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MIIP - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TRAPPC2L - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MLLT6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CHID1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PRR14 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CC2D1B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FAM50A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PACS2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MESDC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on